Project Details
Description
A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003
| Status | Finished |
|---|---|
| Effective start/end date | 10/11/18 → 3/31/20 |
Funding
- BIOGEN INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.